Search results for Cvs Aisle Files

News 5/8/26

Top News CVS Health reports Q1 results: revenue up 6%, ...

CVS (CVS) Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. DATEThursday, May 7, 2026 at 8 a.m. ETCALL PARTICIPANTSChair and Chief Executive Officer — J. David JoynerChief Financial Officer — Brian O. NewmanE...

<![CDATA[Pharmaceutical Executive Daily: CVS Health to Offer Zepbound and Foundayo]]>

Past is Prologue as CVS Returns to Its “CVS Pharmacy” Roots – What it Means for Health Consumers and Retail Health (with...

Going back to its roots, CVS Health announced plans to open 20 “apothecary-style” pharmacies around the U.S., the first of which was sited in Chicago’s West End.                The...

Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program

CVS Health debuts apothecary-style pharmacy locations

CVS Health Launches Apothecary-Style Pharmacy Stores

*CVS Health is reimagining what a pharmacy can look like, and the new vision looks a lot less like a convenience store. The drugstore giant announced on March 30 that it plans to o...

<![CDATA[CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo]]>

CVS Opening New ‘Apothecary-Style’ Pharmacy Locations Nationwide

The drugstore chain is betting that smaller, pharmacy-only stores can rebuild the face-to-face relationship between pharmacists and patients.

CVS offloads Omnicare pharmacy unit in $250m bankruptcy sale

A private equity-backed buyer steps in as the healthcare giant continues to streamline its sprawling empire

LAWSUIT UPDATE: Investors in CVS Health Corporation (NYSE: CVS) Shares Should Contact the Shareholders Foundation in Con...

A lawsuit is currently pending for certain investors in shares of CVS Health Corporation (NYSE:CVS). Investors in NYSE:CVS shares should contact the Shareholders Foundation at mail...

CVS to cover Eli Lilly’s anti-obesity pill, reinstate Zepbound later this year

CVS will cover Eli Lilly’s anti-obesity pill next month, reinstate Zepbound later this year, and keep Wegovy access for Caremark members.

CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo

The top pharmacy benefit manager in the U.S., CVS Caremark, will restore coverage to obesity products from Eli Lilly, allowing a significant number of patients to gain access to th...

CVS Opens First Pharmacy-Focused Location in Washington, D.C. – Petworth

3701 New Hampshire Avenue, NW “Dear PoPville, I don’t know if you’ve had occasion to visit this new “CVS.” But it’s literally just the pharmacy counter and that’s it. Obviously […]

30 money-saving deals at CVS May 10 – May 16

CVS is dangerous at full price and useful when the coupon math lines up. The May 10 to May 16 deals are strongest on allergy medicine, diapers, oral care, hair care, sunscreen, sna...

CVS to cover Eli Lilly’s anti-obesity pill, reinstate Zepbound later this year

CVS will cover Eli Lilly’s anti-obesity pill next month, reinstate Zepbound later this year, and keep Wegovy access for Caremark members.

CVS to expand biosimilar formulary adoptions to improve affordability, accessibility

The move to prioritize biosimilars comes as the company seeks to improve affordability, access and value. Changes will be effective July 1.

CVS restores Eli Lilly Zepbound weight loss drug coverage

CVS Health will restore Eli Lilly’s weight-loss injection Zepbound to its list of covered drugs and also add the drugmaker’s newly approved obesity pill, Foundayo, it said today.

CVS execs say company on track to meet MA margin goals by 2028

CVS Health beat the Street on both earnings and revenue in Q1, posting $2.9 billion in profit for the quarter.